460
Helv. Chim. Acta 2016, 99, 457 – 461
1
1
mmol), and Et N (1 mmol) in EtOH (5 ml) was stirred
3
(C=O), 1602 and 1488 (Ar). H-NMR (300 MHz, (D )
6
3
at r.t. for 4 h. After completion of the reaction (TLC),
the mixture was filtered and the precipitate was washed
with EtOH (4 ml) to afford the pure product 7.
DMSO): 3.2 (s, 3 H); 6.68 (d, J = 7.3, 2 H); 6.82 (t,
J = 7.1, 1 H); 7.17 (t, J = 7.8, 2 H) 7.55 – 7.78 (m, 7 H).
C-NMR (75 MHz, (D )DMSO): 27.0; 94.6; 113.1; 113.8;
3
3
1
3
6
0
0
0
0
3
(
,5 -Diphenyl-3 H-spiro[indole-3,2 -[1,3,4]oxadiazol]-2
1H)-one (3a). Yield: 0.283 g (83%). Yellow powder.
M.p. 227 – 229 °C. IR: 3432 (NH), 1736 (C=O), 1599,
116.2; 121.5; 123.2; 124.9; 128.2; 128.9; 129.6; 129.7; 129.8;
136.1; 141.7; 143.6; 151.1; 169.3. Anal. calc. for
C H BrClN O (468.73): C 56.37, H 3.23, N 8.96; found:
2
2
15
3
2
1
1
486 (Ar), 1129 (C–O). H-NMR (400 MHz, (D6) C 56.31, H 3.18, N 8.89.
3
3
0
0
0
0
DMSO): 6.75 (d, J = 7.6, 2 H); 6.83 (t, J = 7.2, 1 H); 3 ,5 -Diphenyl-2H,3 H-spiro[acenaphthylene-1,2 -[1,3,4]
.06 (d, J = 8.0, 1 H); 7.10 (t, J = 7.6, 1 H); 7.19 (d, oxadiazol]-2-one (5). Yield: 0.338 g (90%). Gray powder.
J = 8.4, 2 H); 7.47 – 7.56 (m, 5 H); 7.82 (d, J = 8.0, 2 M.p. 190 – 192 °C. IR: 1732 (C=O), 1594, 1493 (Ar), 1196
H); 11.14 (s, 1 H). C-NMR (75 MHz, (D )DMSO): 95.5; (C–O). H-NMR (300 MHz, (D )DMSO): 6.52 (d,
J = 5.7, 2 H); 6.71 (t, J = 8.1, 1 H); 7.00 (t, J = 8.1, 2
29.1; 129.3; 131.1; 132.9; 141.8; 143.7; 151.5; 169.8. EI-MS H); 7.51 – 7.53 (m, 3 H); 7.81 – 7.83 (m, 3 H); 7.91 (d,
J = 8.1, 1 H); 8.01 (t, J = 8.9, 1 H); 8.17 (d, J = 4.8, 1
65), 77 (96). Anal. calc. for C H N O (341.36): C H); 8.28 (d, J = 7.2, 1 H); 8.54 (d, J = 6.9, 1 H). C-
3
3
7
3
3
1
3
1
6
6
3
3
3
1
1
11.5; 113.3; 120.6; 122.9; 123.4; 124.0; 125.95; 125.98;
+
70 eV): 341 (M , 80), 313 (100), 208 (49), 105 (69), 91
3
3
3
(
3
3
13
(
2
1
15
3
2
7
5
3
3.89, H 4.43, N 12.31; found: C 73.96, H 4.39, N 12.36.
0
NMR (75 MHz, (D )DMSO): 97.6; 113.9; 121.1; 123.4;
6
0
0
-(4-Chlorophenyl)-1-methyl-3 -phenyl-3 H-spiro[indole-
0
123.7; 124.5; 126.5; 128.4; 128.9; 129.5; 129.7; 129.90;
129.95; 130.8; 131.6; 131.9; 134.4; 141.9; 142.2; 151.9; 192.1.
,2 -[1,3,4]oxadiazol]-2(1H)-one (3b). Yield: 0.339 g
(
(
(
87%). Orange powder. M.p. 215 – 217 °C. IR: 1731 Anal. calc. for C H N O (376.41): C 79.77, H 4.28, N
2
5
16
2
2
1
C=O), 1605 and 1486 (Ar), 1120 (C–O). H-NMR
7.44; found: C 79.72, H 4.36, N 7.48.
0
3
0
300 MHz, (D )DMSO): 3.22 (s, 3 H); 6.70 (d, J = 7.6, 2
3,5-Diphenyl-3H,10 H-spiro[1,3,4-oxadiazole-2,9 -phe-
0
6
3
H); 6.82 (t, J = 7.2, 1 H); 7.15 – 7.27 (m, 4 H); nanthren]-10 -one (7). Yield: 0.354 g (88%). Orange pow-
7
3
13
.50 – 7.57 (m, 4 H); 7.81 (d, J = 8.0, 2 H). C-NMR
der. M.p. 226 – 227 °C. IR: 1699 (C=O), 1595, 1495 (Ar),
1
(
75 MHz, (D )DMSO): 26.9; 95.2; 111.0; 113.9; 121.4; 1162 (C–O). H-NMR (300 MHz, (D )DMSO): 6.67 (d,
6
6
3
3
3
1
1
22.8; 123.3; 124.5; 126.1; 128.2; 129.7; 129.8; 133.5; 136.1;
41.9; 144.4; 151.2; 169.7. Anal. calc. for C H ClN O
2
J = 7.2, 2 H); 6.72 (t, J = 5.2, 1 H); 7.08 (t, J = 6.9, 2
H); 7.46 – 7.49 (m, 3 H); 7.56 – 7.65 (m, 3 H); 7.76 (d,
2
2
16
3
3
3
3
(389.83): C 67.78, H 4.14, N 10.78; found: C 67.83, H 4.18,
N 10.73.
J = 5.4, 2 H); 7.94 (t, J = 6.0, 1 H); 7.99 (d, J = 7.8, 2
3
13
H); 8.42 (d, J = 7.2, 2 H). C-NMR (75 MHz, (D6)
DMSO): 93.0; 114.0; 120.4; 124.6; 125.1; 125.6; 126.3;
0
0
0
0
5
[
-(4-Chlorophenyl)-1-ethyl-3 -phenyl-3 H-spiro[indole-3,2 -
1,3,4]oxadiazol]-2(1H)-one (3c). Yield: 0.343 g (85%). 127.7; 128.6; 129.5; 129.6; 129.9; 130.2; 130.9; 131.4; 131.6;
Orange powder. M.p. 220 – 222 °C. IR: 1732 (C=O), 1641 132.3; 133.4; 136.5; 137.5; 142.0; 150.6; 191.0. Anal. calc.
1
(
(
C=N), 1602, 1535 and 1484 (Ar), 1122 (C–O). H-NMR
for C H N O (402.44): C 80.58, H 4.51, N 6.96; found:
27 18 2 2
3
300 MHz, (D )DMSO): 1.18 (t, J = 6.9, 3 H); 3.77 (m, 2
H); 6.71 (d, J = 8.0, 2 H); 6.80 (t, J = 8.7, 1 H); 6.83 (t,
J = 6.9, 1 H); 7.16 (t, J = 8.0, 2 H); 7.33 (d, J = 8.4, 1
H); 7.55 – 7.57 (m, 1 H); 7.59 (d, J = 8.1, 2 H); 7.83 (d,
J = 8.4, 2 H); 7.94 (d, J = 8.1, 1 H). C-NMR (75 MHz,
D )DMSO): 12.6; 35.1; 95.3; 111.0; 114.0; 121.5; 123.1;
C 80.65, H 4.56, N 6.90.
6
3
3
3
3
3
REFERENCES
1] S. E. Reisman, J. M. Ready, A. Hasuoka, C. J. Smith, J. L.
Wood, J. Am. Chem. Soc. 2006, 128, 1448.
3
[
3
3
13
(
6
[2] T. Mukaiyama, K. Ogata, I. Sato, Y. Hayashi, Chem.–Eur. J.
2014, 20, 13583.
[3] C. Pellegrini, M. Weber, H. J. Borschberg, Helv. Chim. Acta
1
1
23.4; 124.4; 126.4; 128.2; 129.7; 129.8; 133.6; 136.2; 142.1;
43.4; 151.3; 169.3. Anal. calc. for C H ClN O (403.86):
2
3
18
3
2
1
[4] A. Nandakumar, P. Thirumurugan, P. T. Perumal, P. Vembu, M. N.
996, 79, 151.
C 68.40, H 4.49, N 10.40; found: C 68.32, H 4.54, N 10.46.
0
0
0
5
3
-Bromo-5 -(4-chlorophenyl)-3 -phenyl-3 H-spiro[indole-
0
Ponnuswamy, P. Ramesh, Bioorg. Med. Chem. Lett. 2010, 20, 4252.
5] S. U. Maheswari, K. Balamurugan, S. Perumal, P. Yogeeswari,
,2 -[1,3,4]oxadiazol]-2(1H)-one (3d). Yield: 0.400 g (88%).
[
Yellow powder. M.p. 134 – 135 °C. IR: 3438 (NH), 1743
D. Sriram, Bioorg. Med. Chem. Lett. 2010, 20, 7278.
[6] A. Thangamani, Eur. J. Med. Chem. 2010, 45, 6120.
1
(
C=O), 1600 and 1487 (Ar), 1137 (C–O). H-NMR
3
[
7] K. Ding, Y. Lu, Z. Nikolovska-Coleska, S. Qiu, Y. S. Ding, W.
Gao, J. Stuckey, K. Krajewski, P. P. Roller, Y. Tomita, D. A.
Parrish, J. R. Deschamps, S. M. Wang, J. Am. Chem. Soc. 2005,
(
300 MHz, (D )DMSO): 6.75 (d, J = 8.1, 2 H); 6.87 (t,
6
3
3
3
J = 7.5, 1 H); 7.03 (d, J = 7.1, 1 H); 7.22 (t, J = 7.8, 2 H);
3
3
7
.60 (d, J = 8.4, 2 H); 7.68 (d, J = 8.4, 1 H); 7.79 (s, 1 H);
127, 10130.
8] P. Prasanna, K. Balamurugan, S. Perumal, P. Yogeeswari, D.
Sriram, Eur. J. Med. Chem. 2010, 45, 5653.
3
13
7
.83 (d, J = 8.4, 2 H); 11.3 (s, 1 H). C-NMR (75 MHz,
[
(D )DMSO): 95.0; 113.8; 114.5; 115.5; 121.5; 123.4; 125.6;
6
1
1
2
5
28.3; 129.4; 129.7; 129.9; 136.1; 136.2; 141.8; 142.3; 151.3;
71.0. Anal. calc. for C H BrClN O (454.70): C 55.47, H
[9] B. K. S. Yeung, B. Zou, M. Rottmann, S. B. Lakshminarayana,
S. H. Ang, S. Y. Leong, J. Tan, J. Wong, S. Keller-Maerki, C.
Fischli, A. Goh, E. K. Schmitt, P. Krastel, E. Francotte, K.
Kuhen, D. Plouffe, K. Henson, T. Wagner, E. A. Winzeler, F.
Petersen, B. Reto, V. Dartois, T. T. Diagana, T. H. Keller,
J. Med. Chem. 2010, 53, 5155.
21
13
3
2
.88, N 9.24; found: C 55.51, H 2.82, N 9.16.
-Bromo-5 -(4-chlorophenyl)-1-methyl-3 -phenyl-3 H-spiro
0
0
0
0
[indole-3,2 -[1,3,4]oxadiazol]-2(1H)-one (3e). Yield: 0.389 g
83%). Yellow powder. M.p. 232 – 235 °C. IR: 1741
(
www.helv.wiley.com
© 2016 Verlag Helvetica Chimica Acta AG, Z u€ rich